Canaccord lowered the firm’s price target on Quanterix (QTRX) to $4 from $8 and keeps a Hold rating on the shares. The firm updated its model ahead of Q1 results.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTRX:
- Quanterix, PreludeDX highlights AidaBREAST multi-omic assay
- Quanterix debuts Content Innovation Engine at AACR 2026
- Quanterix Balances Growth Optics With Underlying Weakness
- Quanterix: Encouraging Q4 Beat but Fragile Recovery and Limited Visibility Keep Rating at Hold
- Quanterix Faces Significant Supply Chain Risk From Single-Source Instrument Manufacturers